Latest Roche Stories
NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Two Roche employees are being recognized for their significant contributions to industry in New Jersey at the 37th Annual TWIN Awards Dinner held May 5, 2011.
PRINCETON, N.J., April 25, 2011 /PRNewswire/ -- Pharmasset, Inc.
ATLANTIC CITY, N.J., April 8, 2011 /PRNewswire/ -- Hagens Berman LLP, a nationally recognized law firm today praised a jury's verdict that ordered pharmaceutical company Roche (ROG:VX) to pay $2 million to a woman who suffered serious gastrointestinal damage caused by the drug Accutane, while denying similar claims of actor James Marshall and another plaintiff.
NUTLEY, N.J., March 28, 2011 /PRNewswire/ -- Roche announced today that Janet Hammond, MD, Ph.D., has joined the company as Vice President, Translational Medicine - Virology in Pharmaceutical Research and Early Development (pRED).
MADISON, Wis., March 22, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCellÂ® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of developing drug candidates was completed early and is now transitioning into a standard supply agreement.
INDIANAPOLIS and FORT BRAGG, N.C., Feb. 23, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S.
SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc.
PRINCETON, N.J., Feb. 7, 2011 /PRNewswire/ -- Pharmasset, Inc.
MANNHEIM, Germany, Feb.
Focus on cancer vaccines, auto-immune disease diagnostics and treatment DALLAS, Dec.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.